Download PDF
Int J Angiol
DOI: 10.1055/s-0044-1782658
Review Article

Role of Extracorporeal Membrane Oxygenation in the Treatment of Massive Pulmonary Embolism

Hugh A. Glazier
1   Department of Surgery, University Hospital Galway, Galway, Ireland
,
Amir Kaki
2   Division of Cardiology, St. John University Hospital, Detroit, Michigan
3   Department of Medicine, Wayne State University, Detroit, Michigan
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Massive/high-risk pulmonary embolism (PE) is associated with a 30-day mortality rate of approximately 65%. In searching for strategies that may make a dent on this dismal mortality rate, investigators have, over the last decade, shown renewed interest in the potential beneficial role of venoarterial (V-A) extracorporeal membrane oxygenation (ECMO) in the treatment of patients with high-risk PE. There is a dearth of high-quality evidence regarding the value of ECMO in the treatment of massive PE. Studies examining this issue have generally been retrospective, often single center and frequently with small patient numbers. Moreover, these reported studies are not matched with appropriate controls, and, accordingly, it is difficult to regulate for inherent treatment bias. Not surprisingly, there are no randomized controlled trials examining the value of ECMO in the treatment of massive PE, as such trials would pose formidable feasibility challenges. Over the past several years, there has been increasing support for upfront use of V-A ECMO in the treatment of massive PE, when it is complicated by cardiac arrest. In those patients without cardiac arrest, but who have contraindications for thrombolysis, V-A ECMO combined with anticoagulation may be used to stabilize the patient. If after 3 to 5 days, such patients demonstrate persistent right ventricular dysfunction, embolectomy (either surgical or catheter based) should be performed. Well-designed, multicenter, prospective studies are urgently needed to better define the role of V-A ECMO in the treatment of patients with massive PE.

Keywords

massive pulmonary embolism - ECMO - right ventricular - cardiac arrest - large-bore mechanical thrombectomy - thrombolysis - anticoagulation - extracorporeal life support


Publication History

Article published online:
17 April 2024

© 2024. International College of Angiology. This article is published by Thieme.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Russell C, Keshavamurthy S, Saha S. Classification and stratification of pulmonary embolisms. Int J Angiol 2022; 31 (03) 162-165
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Polaková E, Veselka J. Management of massive pulmonary embolism. Int J Angiol 2022; 31 (03) 194-197
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Assouline B, Assouline-Reinmann M, Giraud R. et al. Management of high-risk pulmonary embolism: what is the place of extracorporeal membrane oxygenation?. J Clin Med 2022; 11 (16) 4734
    CrossrefPubMedGoogle Scholar
  • 4 Camporota L. Use of ECMO in massive pulmonary embolism. Paper presented at: 42nd ISICEM International Symposium on Intensive Care & Emergency Medicine; March 23, 2023; Brussels, Belgium. Accessed December 1, 2023 at: https://www.isicem.org/19/Home.asp
    PubMedGoogle Scholar
  • 5 Tohme S, Newman JS, Gasparis C, Manetta F. Massive embolism: knife versus PCI. Int J Angiol 2022; 31 (03) 179-187
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Russell C, Keshavamurthy S. Acute massive and submassive pulmonary embolism: historical considerations/surgical techniques of pulmonary embolectomy/novel applications in donor lungs with pulmonary emboli. Int J Angiol 2022; 31 (03) 188-193
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Kerrigan J, Morse M, Haddad E, Willers E, Ramaiah C. Advances in percutaneous management of pulmonary embolism. Int J Angiol 2022; 31 (03) 203-212
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Giraud R, Laurencet M, Assouline B, De Charrière A, Banfi C, Bendjelid K. Can VA-ECMO be used as an adequate treatment in massive pulmonary embolism?. J Clin Med 2021; 10 (15) 3376
    CrossrefPubMedGoogle Scholar
  • 9 Kmiec L, Philipp A, Floerchinger B. et al. Extracorporeal membrane oxygenation for massive pulmonary embolism as bridge to therapy. ASAIO J 2020; 66 (02) 146-152
    CrossrefPubMedGoogle Scholar
  • 10 Patel S, Thulasidasan N, Thomson B. et al. Interventional therapies in acute pulmonary embolus-current trends and future directions. Br J Radiol 2023; 96 (1149): 20221151
    CrossrefPubMedGoogle Scholar
  • 11 Elder M, Blank N, Shemesh A. et al. Mechanical circulatory support for high-risk pulmonary embolism. Interv Cardiol Clin 2018; 7 (01) 119-128
    PubMedGoogle Scholar
  • 12 Brener MI, Burkoff D. Percutaneous mechanical circulatory support: Impella, intra-aortic balloon counterpulsation, TandemHeart, Extracorporeal Bypass, and right ventricular support devices. In: Moscucci M. ed. Grossman & Baim's Cardiac Catheterization, Angiography and Intervention. Philadelphia: Lippincott Williams & Williams; 2021: 1588-1660
    Google Scholar
  • 13 Guglin M, Zucker MJ, Bazan VM. et al. Venoarterial ECMO for adults: JACC scientific expert panel. J Am Coll Cardiol 2019; 73 (06) 698-716
    CrossrefPubMedGoogle Scholar
  • 14 Shumacker HB. John Heysham Gibbon, Jr.: September 29, 1903-February 5, 1973. Biogr Mem Natl Acad Sci 1982; 53: 213-247
    PubMedGoogle Scholar
  • 15 Gibbon Jr JH. The development of the heart-lung apparatus. Rev Surg 1970; 27 (04) 231-244
    PubMedGoogle Scholar
  • 16 Gibbon Jr JH. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 1954; 37 (03) 171-185 , passim
    PubMedGoogle Scholar
  • 17 Bartlett RH, John H. John H Gibbon Jr Lecture. Extracorporeal life support: Gibbon fulfilled. J Am Coll Surg 2014; 218 (03) 317-327
    CrossrefPubMedGoogle Scholar
  • 18 Davies MJ, Arsiwala SS, Moore HM, Kerr S, Sosnowski AW, Firmin RK. Extracorporeal membrane oxygenation for the treatment of massive pulmonary embolism. Ann Thorac Surg 1995; 60 (06) 1801-1803
    CrossrefPubMedGoogle Scholar
  • 19 Maggio P, Hemmila M, Haft J, Bartlett R. Extracorporeal life support for massive pulmonary embolism. J Trauma 2007; 62 (03) 570-576
    PubMedGoogle Scholar
  • 20 George B, Parazino M, Omar HR. et al. A retrospective comparison of survivors and non-survivors of massive pulmonary embolism receiving veno-arterial extracorporeal membrane oxygenation support. Resuscitation 2018; 122: 1-5
    CrossrefPubMedGoogle Scholar
  • 21 Ghoreishi M, DiChiacchio L, Pasrija C. et al. Predictors of recovery in patients supported with venoarterial extracorporeal membrane oxygenation for acute massive pulmonary embolism. Ann Thorac Surg 2020; 110 (01) 70-75
    CrossrefPubMedGoogle Scholar
  • 22 Meneveau N, Guillon B, Planquette B. et al. Outcomes after extracorporeal membrane oxygenation for the treatment of high-risk pulmonary embolism: a multicentre series of 52 cases. Eur Heart J 2018; 39 (47) 4196-4204
    CrossrefPubMedGoogle Scholar
  • 23 Kaso ER, Pan JA, Salerno M. et al. Venoarterial extracorporeal membrane oxygenation for acute massive pulmonary embolism: a meta-analysis and call to action. J Cardiovasc Transl Res 2022; 15 (02) 258-267
    CrossrefPubMedGoogle Scholar
  • 24 Karami M, Mandigers L, Miranda DDR. et al; DUTCH ECLS Study Group. Survival of patients with acute pulmonary embolism treated with venoarterial extracorporeal membrane oxygenation: a systematic review and meta-analysis. J Crit Care 2021; 64: 245-254
    CrossrefPubMedGoogle Scholar
  • 25 Hobohm L, Sagoschen I, Habertheuer A. et al. Clinical use and outcome of extracorporeal membrane oxygenation in patients with pulmonary embolism. Resuscitation 2022; 170: 285-292
    CrossrefPubMedGoogle Scholar
  • 26 Konstantinides SV, Meyer G, Becattini C. et al. The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Respir J 2019; 54: 1901647
    CrossrefPubMedGoogle Scholar
  • 27 Vedantham S. Massive pulmonary embolism: optimizing collaborative care and endovascular therapy. Circ Cardiovasc Interv 2023; 16 (10) e013536
    CrossrefPubMedGoogle Scholar
  • 28 Silver MJ, Gibson CM, Giri J. et al. Outcomes in high-risk pulmonary embolism patients undergoing FlowTriever mechanical thrombectomy or other contemporary therapies: results from the FLAME study. Circ Cardiovasc Interv 2023; 16 (10) e013406
    CrossrefPubMedGoogle Scholar
  • 29 Glazier JJ, Patiño-Velasquez S, Oviedo C. The Pulmonary Embolism Response Team: rationale, operation, and outcomes. Int J Angiol 2022; 31 (03) 198-202
    Article in Thieme ConnectPubMedGoogle Scholar